Stay updated on DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial
Sign up to get notified when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.

Latest updates to the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a Nat Med publication citation for a high-dose nusinersen phase 3 trial and updated the page revision to v3.4.2; the NIH funding-status notice was removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a general site operation notice about government funding and NIH Clinical Center status, and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedUI/metadata updates include showing the glossary, displaying the QC update status, capitalization tweaks, and a new page revision to v3.4.0; no core study content, endpoints, eligibility criteria, or safety data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded a new publication reference to Publications: Wang X et al., Musculoskeletal deformities in children with spinal muscular atrophy: a multicenter cross-sectional study with longitudinal follow-up (Ann Phys Rehabil Med, 2026). The study record version was updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section expanded to enumerate individual sites by region and country (e.g., California, Ontario, Beijing Municipality, Minas Gerais, Rio Grande do Sul, etc.), replacing the previous grouped location entries. Revision: v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedThe page's revision note was updated to v3.3.2, replacing the previous v3.3.1. To avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.